PubRank

Thomas E Starzl

Author PubWeight™ 80.83‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 2002 3.96
2 Generation of cloned transgenic pigs rich in omega-3 fatty acids. Nat Biotechnol 2006 3.07
3 VENO-VENOUS BYPASS WITHOUT SYSTEMIC ANTICOAGULATION IN CANINE AND HUMAN LIVER TRANSPLANTATION. Surg Forum 1983 2.30
4 THE USE OF COMBINED PRESERVATION TECHNIQUES FOR EXTENDED STORAGE OF ORTHOTOPIC LIVER HOMOGRAFTS. Surg Gynecol Obstet 1968 2.20
5 Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath. J Am Coll Surg 2005 1.93
6 The hepatoadrenal syndrome: a common yet unrecognized clinical condition. Crit Care Med 2005 1.75
7 Complications of right lobe living donor liver transplantation. J Hepatol 2009 1.73
8 Alemtuzumab preconditioning with tacrolimus monotherapy-the impact of serial monitoring for donor-specific antibody. Transplantation 2008 1.62
9 Immunosuppression for liver transplantation in HCV-infected patients: mechanism-based principles. Liver Transpl 2005 1.61
10 EFFECT OF CYCLOSPORIN ON HEPATIC REGENERATION. Surg Forum 1986 1.59
11 Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning. Ann Surg 2003 1.52
12 Functionally important glycosyltransferase gain and loss during catarrhine primate emergence. Proc Natl Acad Sci U S A 2006 1.46
13 Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus. Transplantation 2004 1.43
14 Transplantation of en bloc pediatric kidneys when the proximal vascular cuff is too short. Transplantation 2007 1.42
15 SUCCESSFUL ORTHOTOPIC TRANSPLANTATION OF LIVER HOMOGRAFTS AFTER EIGHT TO TWENTY-FIVE HOURS PRESERVATION. Surg Forum 1967 1.37
16 Antilymphoid antibody preconditioning and tacrolimus monotherapy for pediatric kidney transplantation. J Pediatr 2006 1.36
17 Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression. Ann Surg 2013 1.30
18 Origin of lymph node-derived lymphocytes in human hepatic allografts. Clin Transpl 1989 1.24
19 Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis. Hepatology 2002 1.21
20 Molecular basis of evolutionary loss of the alpha 1,3-galactosyltransferase gene in higher primates. J Biol Chem 2001 1.18
21 Pregnancy after liver transplantation with tacrolimus immunosuppression: a single center's experience update at 13 years. Transplantation 2003 1.18
22 OKT3 and viral disease in pediatric liver transplant recipients. Clin Transplant 1991 1.11
23 Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy. J Thorac Cardiovasc Surg 2005 1.10
24 Augmenter of liver regeneration: an important intracellular survival factor for hepatocytes. J Hepatol 2008 1.04
25 The course of type 1 hepato-renal syndrome post liver transplantation. Nephrol Dial Transplant 2005 1.02
26 Humoral Antibodies in Patients After Renal Homotransplantation. Transplantation 1967 0.96
27 Intestinal transplantation under tacrolimus monotherapy after perioperative lymphoid depletion with rabbit anti-thymocyte globulin (thymoglobulin). Am J Transplant 2005 0.95
28 Human dominant-negative class II transactivator transgenic pigs - effect on the human anti-pig T-cell immune response and immune status. Immunology 2013 0.95
29 Functional characteristics of lymphocytes propagated from a human multivisceral allograft. Clin Transplant 1990 0.94
30 Living-related donor renal transplantation in HIV+ recipients using alemtuzumab preconditioning and steroid-free tacrolimus monotherapy: a single center preliminary experience. Transplantation 2004 0.91
31 Tacrolimus (FK506)-Associated Renal Pathology. Adv Anat Pathol 1997 0.90
32 Four-color flow cytometric analysis of peripheral blood donor cell chimerism. Hum Immunol 2003 0.89
33 Portacaval shunt causes apoptosis and liver atrophy in rats despite increases in endogenous levels of major hepatic growth factors. J Hepatol 2002 0.88
34 Immunosuppressive therapy and tolerance of organ allografts. N Engl J Med 2008 0.88
35 ALLOREACTIVE T LYMPHOCYTES CULTURED FROM LIVER TRANSPLANT BIOPSIES: ASSOCIATIONS OF HLA SPECIFICITY WITH CLINICOPATHOLOGICAL FINDINGS. Clin Transplant 1988 0.87
36 The treatment of penetrating wounds of the inferior vena cava. Surgery 1962 0.86
37 Cholera toxin-sensitive GTP-binding protein-coupled activation of augmenter of liver regeneration (ALR) receptor and its function in rat kupffer cells. J Cell Physiol 2010 0.85
38 Alemtuzumab induction and tacrolimus monotherapy in pancreas transplantation: One- and two-year outcomes. Transplantation 2006 0.82
39 Smooth muscle tumor arising de novo in a liver allograft: A case report. Clin Transplant 1991 0.82
40 Simultaneous bone marrow and intestine transplantation promotes marrow-derived hematopoietic stem cell engraftment and chimerism. Blood 2006 0.82
41 Early passenger leukocyte migration and acute immune reactions in the rat recipient spleen during liver engraftment: with particular emphasis on donor major histocompatibility complex class II+ cells. Transplantation 2002 0.81
42 Pancreatic transplantation at the University of Pittsburgh. Clin Transpl 2004 0.81
43 Hepatic artery thrombosis following pediatric liver transplantation: Assessment of blood flow measurement in allografts. Clin Transplant 1989 0.81
44 Experience with posttransplant lymphoproliferative disorders in solid organ transplant recipients. Clin Transplant 1992 0.80
45 The difficulty of eliminating donor leukocyte microchimerism in rat recipients bearing established organ allografts. Transplantation 2006 0.78
46 Induction of Pancreatic Islet Graft Acceptance: The Role of Antigen Presenting Cells. Transplant Sci 1992 0.78
47 Cadaveric renal transplantation using kidneys from donors greater than 60 years old. Clin Transplant 1992 0.78
48 Relative contribution of direct and indirect allorecognition in developing tolerance after liver transplantation. Liver Transpl 2008 0.78
49 Kidney after nonrenal transplantation-the impact of alemtuzumab induction. Transplantation 2009 0.78
50 Renal transplantation in children managed with lymphocyte depleting agents and low-dose maintenance tacrolimus monotherapy. Transplantation 2007 0.78
51 Reversal of Graft-Versus-Host Disease with Infusion of Stored Autologous Bone Marrow Cells Following Combined Liver-Bone Marrow Allotransplantation in Man. Transplant Sci 1993 0.78
52 Pancreas and islet cell transplantation. Best Pract Res Clin Gastroenterol 2002 0.78
53 LIVER TRANSPLANTATION IN MAN. Ann N Y Acad Sci 1970 0.78
54 Tolerance for organ recipients: a clash of paradigms. Liver Transpl 2006 0.78
55 Protocol biopsies should not (yet) be the standard of care in pediatric renal transplant recipients. Pediatr Transplant 2006 0.78
56 Kidney/Bone Marrow Transplantation. Dial Transplant 1996 0.76
57 Kidney after Extrarenal Transplantation - The Impact of Alemtuzumab Induction. Transplantation 2008 0.75
58 Successful salvage of mucormycosis infection of the forearm and osteomyelitis of the ulna. Hand (N Y) 2008 0.75
59 CRITICAL CARE MEDICINE AND LIVER TRANSPLANTATION. Crit Care 1985 0.75
60 World's longest surviving liver-pancreas recipient. Liver Transpl 2007 0.75
61 Causes of death after liver transplantation in children treated with cyclosporine and steroids. Clin Transplant 1989 0.75
62 Long-term results of cyclosporine-steroid therapy in 131 non-matched cadaveric renal transplants. Clin Transplant 1987 0.75
63 Prevention of Transplant Rejection: Can Tolerance be Achieved with Immunosuppressive Treatment? Clin Immunother 1996 0.75
64 Cold heparinized lactated Ringers with procaine (HeLP) preservation fluid in 266 living donor kidney transplantations. Transplantation 2007 0.75
65 Effect of homograft ischemia upon serum proteins after orthotopic liver transplantation. Surgery 1968 0.75
66 The Problem of Frostbite in Civilian Medical Practice. Surg Clin North Am 1963 0.75
67 Hepatic Regeneration. Viewp Dig Dis 1979 0.75
68 Kaposi's sarcoma in two primary liver allograft recipients occurring under FK506 immunosuppression. Clin Transplant 1993 0.75
69 Liver Transplantation in the World: Present Conditions of Liver Transplantation from Cadaver Donors in USA. Kusuri No Chishiki 1995 0.75
70 On the crossroad between tolerance and posttransplant lymphoma. Curr Opin Organ Transplant 1997 0.75
71 Pancreatic complications following orthotopic liver transplantation. Clin Transplant 1992 0.75
72 WHICH LIVER-DESEASE PATIENTS NEED A TRANSPLANT?: Organ replacement has come into its own as a treatment for end-stage liver disease. A team of experts from two leading transplant centers reviews current indications, survival rates, and methods of evaluating candidates for operation. Hosp Rec Study 1988 0.75
73 Blood Vessel Bank: Organization and Function. Bull Univ Miami Sch Med Jackson Meml Hosp 1957 0.75
74 Transplantation. JAMA 1986 0.75
75 Correction of congenital hyperbilirubinemia in homozygous Gunn rats by xenotransplantation of hamster livers. Xenotransplantation 1997 0.75
76 LONG TERM RESULTS OF HEPATIC TRANSPLANTATION DURING THE CYCLOSPORINE ERA: THE PITTSBURGH EXPERIENCE. Transplant Clin Immunol 1987 0.75
77 Fifty years later. Clin Transpl 2013 0.75
78 Transplant innovation and ethical challenges: what have we learned? A collection of perspectives and panel discussion. Cleve Clin J Med 2008 0.75
79 Recurrent liver disease after liver transplantation. Forum (Genova) 1997 0.75